secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0000950170-22-020527
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene raises $10.8M in registered direct offering and secures $5M debt facility from Maryland
--------------------------------------------------------------------------------

- Registered direct offering of 10,723,926 shares at $1.01/share; gross proceeds of $10.8M.
- Proceeds to fund clinical development of CNM-Au8 for ALS and general corporate purposes.
- Also entered $5M loan facility with Maryland DHCD (SSBCI), non-dilutive, conditional on matching equity.
- Both transactions extend cash runway into Q3 2023; direct offering closing expected Nov 2, 2022.
- Offering made to existing stockholders including board affiliates; no placement agent or commissions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000095017022020527/0000950170-22-020527-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000095017022020527/clnn-20221031.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-020527

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer